Nabriva Therapeutics plc Net Income
Nabriva Therapeutics plc reported Net Income of -$12.06 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-10-19.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-10-19
- Nabriva Therapeutics plc net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$12.06M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$8.70M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for the quarter ending 2022-12-31 was -$22.78M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for the quarter ending 2022-09-30 was -$11.51M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for fiscal 2022 was -$57.19M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for fiscal 2021 was -$49.45M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for fiscal 2020 was -$69.48M.
- Nabriva Therapeutics plc net income (loss) attributable to parent for fiscal 2019 was -$82.76M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$12.06M 10-Q · filed 2023-10-19 | -$20.76M 10-Q · filed 2023-10-19 | -$43.54M derived: sum of 3 quarters · filed 2023-10-19 | -$55.05M derived: sum of 4 quarters · filed 2023-10-19 |
| 2023-03-31 | -$8.70M 10-Q · filed 2023-10-19 | -$31.48M derived: sum of 2 quarters · filed 2023-10-19 | -$42.99M derived: sum of 3 quarters · filed 2023-10-19 | -$54.07M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-12-31 | -$22.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$34.29M derived: sum of 2 quarters · filed 2023-04-17 | -$45.37M derived: sum of 3 quarters · filed 2023-10-19 | -$57.19M 10-K · filed 2023-04-17 |
| 2022-09-30 | -$11.51M 10-Q · filed 2022-11-10 | -$22.59M derived: sum of 2 quarters · filed 2023-10-19 | -$34.41M 10-Q · filed 2022-11-10 | -$47.47M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-06-30 | -$11.07M 10-Q · filed 2023-10-19 | -$22.89M 10-Q · filed 2023-10-19 | -$35.96M derived: sum of 3 quarters · filed 2023-10-19 | -$46.61M derived: sum of 4 quarters · filed 2023-10-19 |
| 2022-03-31 | -$11.82M 10-Q · filed 2023-10-19 | -$24.88M derived: sum of 2 quarters · filed 2023-10-19 | -$35.53M derived: sum of 3 quarters · filed 2023-10-19 | -$47.29M derived: sum of 4 quarters · filed 2023-10-19 |
| 2021-12-31 | -$13.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$23.71M derived: sum of 2 quarters · filed 2023-04-17 | -$35.47M derived: sum of 3 quarters · filed 2023-04-17 | -$49.45M 10-K · filed 2023-04-17 |
| 2021-09-30 | -$10.65M 10-Q · filed 2022-11-10 | -$22.41M derived: sum of 2 quarters · filed 2022-11-10 | -$36.39M 10-Q · filed 2022-11-10 | -$54.22M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-06-30 | -$11.75M 10-Q · filed 2022-11-10 | -$25.73M 10-Q · filed 2022-08-03 | -$43.57M derived: sum of 3 quarters · filed 2023-04-17 | -$56.52M derived: sum of 4 quarters · filed 2023-04-17 |
| 2021-03-31 | -$13.98M 10-Q · filed 2022-11-10 | -$31.81M derived: sum of 2 quarters · filed 2023-04-17 | -$44.77M derived: sum of 3 quarters · filed 2023-04-17 | -$60.21M derived: sum of 4 quarters · filed 2023-04-17 |
| 2020-12-31 | -$17.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$30.78M derived: sum of 2 quarters · filed 2023-04-17 | -$46.23M derived: sum of 3 quarters · filed 2023-04-17 | -$69.48M 10-K · filed 2023-04-17 |
| 2020-09-30 | -$12.95M 10-Q · filed 2021-11-09 | -$28.39M derived: sum of 2 quarters · filed 2021-11-09 | -$51.65M 10-Q · filed 2021-11-09 | -$74.70M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$15.44M 10-Q · filed 2021-11-09 | -$38.70M 10-Q · filed 2021-08-05 | -$61.74M derived: sum of 3 quarters · filed 2021-11-09 | -$79.54M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-03-31 | -$23.26M 10-Q · filed 2021-11-09 | -$46.30M derived: sum of 2 quarters · filed 2021-11-09 | -$64.10M derived: sum of 3 quarters · filed 2021-11-09 | -$85.81M derived: sum of 4 quarters · filed 2021-11-09 |
| 2019-12-31 | -$23.05M 10-K · filed 2020-03-12 | -$40.84M derived: sum of 2 quarters · filed 2020-11-05 | -$62.55M derived: sum of 3 quarters · filed 2020-11-05 | -$82.76M 10-K · filed 2022-03-29 |
| 2019-09-30 | -$17.80M 10-Q · filed 2020-11-05 | -$39.50M derived: sum of 2 quarters · filed 2020-11-05 | -$59.72M 10-Q · filed 2020-11-05 | -$90.54M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$21.71M 10-Q · filed 2020-11-05 | -$41.92M 10-Q · filed 2020-08-06 | -$72.75M derived: sum of 3 quarters · filed 2020-11-05 | -$125.57M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-03-31 | -$20.22M 10-Q · filed 2020-11-05 | -$51.04M derived: sum of 2 quarters · filed 2020-11-05 | -$103.87M derived: sum of 3 quarters · filed 2020-11-05 | -$121.65M derived: sum of 4 quarters · filed 2020-11-05 |
| 2018-12-31 | -$30.82M 10-K · filed 2020-03-12 | -$83.65M derived: sum of 2 quarters · filed 2020-03-12 | -$101.44M derived: sum of 3 quarters · filed 2020-03-12 | -$114.78M 10-K · filed 2021-03-11 |
| 2018-09-30 | -$52.83M 10-K · filed 2020-03-12 | -$70.61M derived: sum of 2 quarters · filed 2020-03-12 | -$83.95M 10-Q · filed 2019-11-12 | -$106.22M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | -$17.79M 10-K · filed 2020-03-12 | -$31.13M 10-Q · filed 2019-08-08 | -$53.39M derived: sum of 3 quarters · filed 2020-03-12 | -$75.66M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | -$13.34M 10-K · filed 2020-03-12 | -$35.60M derived: sum of 2 quarters · filed 2020-03-12 | -$57.87M derived: sum of 3 quarters · filed 2020-03-12 | -$72.47M derived: sum of 4 quarters · filed 2020-03-12 |
| 2017-12-31 | -$22.26M 10-K · filed 2019-03-12 | -$44.53M derived: sum of 2 quarters · filed 2019-03-12 | -$59.13M derived: sum of 3 quarters · filed 2019-03-12 | -$74.36M 10-K · filed 2020-03-12 |
| 2017-09-30 | -$22.27M 10-K · filed 2019-03-12 | -$36.87M derived: sum of 2 quarters · filed 2019-03-12 | -$52.09M 10-Q · filed 2018-11-06 | -$67.28M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-06-30 | -$14.60M 10-K · filed 2019-03-12 | -$29.82M 10-Q · filed 2018-08-09 | -$45.01M derived: sum of 3 quarters · filed 2019-03-12 | -$59.01M derived: sum of 4 quarters · filed 2019-03-12 |
| 2017-03-31 | -$15.22M 10-K · filed 2019-03-12 | -$30.41M derived: sum of 2 quarters · filed 2019-03-12 | -$44.41M derived: sum of 3 quarters · filed 2019-03-12 | -$56.51M derived: sum of 4 quarters · filed 2019-03-12 |
| 2016-12-31 | -$15.19M 10-K · filed 2018-03-16 | -$29.19M derived: sum of 2 quarters · filed 2018-03-16 | -$41.29M derived: sum of 3 quarters · filed 2018-03-16 | -$54.89M 10-K · filed 2019-03-12 |
| 2016-09-30 | -$14.00M 10-K · filed 2018-03-16 | -$26.10M derived: sum of 2 quarters · filed 2018-03-16 | -$39.70M derived: sum of 3 quarters · filed 2018-03-16 | -$47.67M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | -$12.10M 10-K · filed 2018-03-16 | -$25.70M derived: sum of 2 quarters · filed 2018-03-16 | -$33.67M derived: sum of 3 quarters · filed 2018-03-16 | -$42.09M derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | -$13.60M 10-K · filed 2018-03-16 | -$21.56M derived: sum of 2 quarters · filed 2018-03-16 | -$29.98M derived: sum of 3 quarters · filed 2018-03-16 | -$54.50M derived: sum of 4 quarters · filed 2018-03-16 |
| 2015-12-31 | -$7.96M 10-K · filed 2017-03-24 | -$16.39M derived: sum of 2 quarters · filed 2017-03-24 | -$40.91M derived: sum of 3 quarters · filed 2017-03-24 | -$46.96M 10-K · filed 2018-03-16 |
| 2015-09-30 | -$8.42M 10-K · filed 2017-03-24 | -$32.94M derived: sum of 2 quarters · filed 2017-03-24 | -$39.00M derived: sum of 3 quarters · filed 2017-03-24 | |
| 2015-06-30 | -$24.52M 10-K · filed 2017-03-24 | -$30.58M derived: sum of 2 quarters · filed 2017-03-24 | ||
| 2015-03-31 | -$6.06M 10-K · filed 2017-03-24 | |||
| 2014-12-31 | -$14.22M 10-K · filed 2017-03-24 |